On April 13, 2023 Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer, reported that it will participate in four upcoming investor conferences (Press release, Allogene, APR 13, 2023, View Source [SID1234630029]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Canaccord Genuity – CG Horizons in Oncology Virtual
Thursday, April 20, 2023
8:00AM PT/11:00AM ET

BofA Securities 2023 Health Care Conference
Wednesday, May 10, 2023
4:20PM PT/7:20PM ET

The JMP Securities Life Sciences Conference
Monday, May 15, 2023
8:30AM PT/11:30AM ET

2023 RBC Capital Markets Global Healthcare Conference
Tuesday, May 16, 2023
1:35PM PT/4:35PM ET

Any available webcasts will be posted to the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company’s website for approximately 30 days.